Welcome to our dedicated page for International Flavors&Fragranc news (Ticker: IFF), a resource for investors and traders seeking the latest updates and insights on International Flavors&Fragranc stock.
International Flavors & Fragrances Inc. (IFF) is a leading innovator in creating sensorial experiences that drive the world of flavors and fragrances. Headquartered in New York, the company partners with customers globally to develop unique products for the food, beverage, health, personal care, and household goods industries. With a strong commitment to discovery and innovation, IFF continuously explores new possibilities in both fine fragrances and beauty, as well as in beloved foods and beverages.
IFF's core businesses include the Nourish segment, which accounts for nearly half of its revenue. This segment specializes in producing flavors, texturants, and plant-based proteins, providing essential ingredients that enhance the appeal and functionality of food products. Additionally, the Health & Biosciences division, generating roughly one-fourth of the company's revenue, is renowned for its expertise in probiotics and enzymes, making significant contributions to health and wellness solutions.
The company leverages its global team of 7,300 professionals along with leading consumer insights, research and development, and creative expertise to deliver differentiated products. Their proprietary formulations and custom solutions are a testament to their innovative approach and customer-centric focus.
IFF has recently made remarkable advancements in excipient technology, presenting its comprehensive range at global events such as CPhI Japan 2024 and Vitafoods Europe 2024. These showcases highlight the company's commitment to driving pharmaceutical innovation, with notable products like METHOCEL™, ETHOCEL™, and POLYOX™ under its new controlled release platform, 'Timing is Everything'. This new platform emphasizes the importance of controlled release in pharmaceutical therapies, aiming to improve patient compliance and treatment efficacy.
IFF continues to expand its innovative offerings and partnerships, demonstrating a significant impact across various industries. The company's dedication to sustainability and precision in science and creativity positions it as a key player in transforming everyday experiences and contributing to a better world.
For more detailed information about their latest projects and developments, visit their official website at iff.com.
IFF has launched SEAFLOUR™, a nutrient-dense hydrocolloid derived from non-GMO red seaweed, catering to the growing demand for clean label products in the U.S. The ingredient is suitable for plant-based beverages, offering stability, texture, and nutritional benefits without allergens. SEAFLOUR™ aids manufacturers in reducing fat and sugar levels while enhancing product quality. The sourcing supports local farming and aligns with IFF's 2030 sustainability goals, including responsible-seaweed practices.
IFF (NYSE: IFF) will release its first quarter 2022 earnings results after market close on May 9, 2022. A live webcast discussing the results will be hosted by management on May 10, 2022, at 9:00 a.m. ET. Investors can access the webcast and slide presentation on the company's website, with a recorded version available for playback. IFF is a leader in food, beverage, health, biosciences, and scent, providing innovative solutions to meet global needs.
Smart Cups has announced a multi-year collaboration with IFF, focusing on sustainable consumer products in the health and wellness sector. This partnership will leverage IFF's extensive ingredient portfolio and Smart Cups Technology, which allows for printing ingredients directly on surfaces. The initiative aims to reduce carbon footprints by minimizing the need to ship liquids. Products developed through this collaboration are scheduled for release in 2022, with a broader goal of advancing eco-conscious manufacturing practices.
IFF (NYSE: IFF) has finalized its acquisition of Health Wright Products (HWP), a prominent player in dietary supplement formulation and manufacturing. Known for high-quality nutritional supplements, HWP will enhance IFF's Health & Biosciences division, focusing on probiotic products. The acquisition will retain HWP’s workforce of over 225 employees, and IFF plans to expand HWP's capabilities to meet customer demands. Financial terms of the deal remain undisclosed. This strategic move aims to strengthen IFF’s market position in health and nutrition.
IFF's Industrial Solutions will debut at the American Coatings Show from April 5-7, 2022, showcasing their renewable polymer portfolio and expertise. At booth 1054, they will present solutions for coating and printing ink challenges that enhance functionality, improve savings, and promote worker safety. Notable products include Lattice® NTC, WALSRODER™ Nitrocellulose, and ETHOCEL™. Key presentations by IFF scientists will focus on bio-based paint formulations on April 5 and 6.
IFF (NYSE: IFF) has announced broad-based pricing actions across its four divisions: Nourish, Health & Biosciences, Scent, and Pharma Solutions. This decision is a direct response to rising raw material, energy, and logistics costs due to the geopolitical climate. The company will implement dynamic pricing, with adjustments based on specific product cost increases, ensuring that product prices reflect current market conditions. Account managers will communicate pricing changes to specific clients.
International Flavors & Fragrances (NYSE: IFF) has announced the impending departure of Susana Suarez Gonzalez, PhD, Executive Vice President and Chief Human Resources and Diversity & Inclusion Officer. Peter Sommers, currently VP of Global People Services, will serve as the Interim Chief Human Resources Officer. Dr. Suarez Gonzalez will assist during the transition. CEO Frank Clyburn praised her substantial contributions over six years and expressed confidence in Sommers' capabilities to continue the company’s talent and culture objectives.
IFF (NYSE: IFF) has declared a quarterly cash dividend of
IFF (NYSE: IFF) has announced its agreement to acquire Health Wright Products, LLC (HWP), a prominent player in dietary supplement formulation and capsule manufacturing. HWP, based in Clackamas, Oregon, generated approximately $100 million in revenue in 2021 and employs over 225 people. This acquisition aims to enhance IFF's Health & Biosciences division by integrating HWP's capabilities for custom formulations and packaging, driving innovation in probiotic products. The transaction is expected to close in Q1 2022, pending customary conditions and regulatory approvals.
IFF (NYSE: IFF) has announced that Executive Vice President and CFO Glenn Richter will speak at the Consumer Analyst Group of New York's annual conference on February 24, 2022. His pre-recorded presentation is set to begin at 3:00 p.m. ET. A replay of the session will be available later on ir.iff.com. IFF is a leader in the food, beverage, scent, health, and biosciences sectors, creating solutions that promote a better world.
FAQ
What is the current stock price of International Flavors&Fragranc (IFF)?
What is the market cap of International Flavors&Fragranc (IFF)?
What does International Flavors & Fragrances Inc. (IFF) do?
What are the core business segments of IFF?
Where is IFF headquartered?
How many employees does IFF have?
What are some recent innovations by IFF?
What is the significance of the 'Timing is Everything' platform?
How does IFF support the food industry?
What role does IFF play in the health sector?
Where can I find more information about IFF's products and services?
What is IFF's approach to innovation?
